Last reviewed · How we verify
NCT04898270
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Phase 4 trial testing Flupentixol in Schizophrenia; Psychosis in 30 participants. Completed in 20 April 2021.
31 December 2020
Quick facts
| Lead sponsor | Taichung Veterans General Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 19 December 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 20 April 2021 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Flupentixol (FLUPENTIXOL) — full drug profile →
- Multi-acting receptor-targeted antipsychotics (MARTAs) — full drug profile →
Conditions studied
- Schizophrenia; Psychosis — all drugs for Schizophrenia; Psychosis →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Flupentixol — all drugs for Flupentixol →
- Antipsychotic Agents — all drugs for Antipsychotic Agents →
Sponsor
Taichung Veterans General Hospital
Who can join
Adults 20 to 65, any sex, with Schizophrenia; Psychosis or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fute (Flupentixol) combined with MARTAs (Multiple-Acting Receptor Targeted Antipsychotics) drugs has its clinical efficacy toward positive symptoms and might reduce the metabolic syndrome-related factors in patients. This study is the first clinical trial to explore the treatment of patients with flupentixol combined with MARTAs. However, due to research limitations, the number of patients who participated in the clinical trial is small, and it depends on subsequent larger-scale clinical trials for more in-depth verification.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04898270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia; Psychosis
Currently open trials in the same condition.
- NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
- NCT06341517 — Brain Circuitry Therapeutics for Schizophrenia · NA · recruiting
- NCT05550155 — Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations · NA · recruiting
- NCT05763966 — Uppsala Psychosis Cohort · recruiting
- NCT05858255 — Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study · NA · recruiting
Other Taichung Veterans General Hospital trials
Trials by the same sponsor.
- NCT06858436 — SGLT2 Inhibitor Utilization Re-perfusion Therapy · Phase 4 · not yet recruiting
- NCT07453953 — A Comparison of Clinical Efficacy of Mytocel MSK With AMT and PRP Injections in Patients With Knee Osteoarthritis · EARLY_PHASE1 · not yet recruiting
- NCT07487636 — 4DryField PH and Head and Neck Operations. · NA · enrolling by invitation
- NCT07284017 — The Impact of Neuronavigation in rTMS for Hemiplegic Stroke Patients. · NA · not yet recruiting
- NCT07363876 — The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04898270 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taichung Veterans General Hospital
- Last refreshed: 24 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04898270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing